Literature DB >> 27451930

Intralesional methotrexate as an adjuvant treatment for pyoderma gangrenosum: A case report.

Constanza Del Puerto1, Cristián P Navarrete-Dechent1, Juan E Carrasco-Zuber1, Cristián Vera-Kellet2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27451930     DOI： 10.4103/0378-6323.186497

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  3 in total

Review 1.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233

2.  Resolution of Keratoacanthoma Type Squamous Cell Carcinoma Following Intralesional Therapy With Methotrexate.

Authors:  Andrea Sisti; Maria T Huayllani; Daniel Boczar; Scott Fosko; Antonio J Forte
Journal:  Cureus       Date:  2020-05-13

3.  Intramatricial methotrexate for treatment of resistant acrodermatitis continua of Hallopeau: An alternative in COVID-19.

Authors:  Anuradha Jindal; Sandhiya Ramesh; Malcom Noronha; Kantilatha Pai; Sathish Pai
Journal:  Dermatol Ther       Date:  2020-07-02       Impact factor: 3.858
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.